Perrigo (NYSE:PRGO) is a leading global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals. The company develops, manufactures and distributes a broad portfolio of branded and private-label products spanning pain relief, digestive health, vitamins, minerals and supplements, infant formulas, and women’s health. Perrigo’s offerings are sold through supermarket chains, pharmacies, mass merchandisers, and healthcare providers under both its own labels and those of retail partners.
Founded in 1887 in Allegan, Michigan, Perrigo has grown from a regional supplier to a global healthcare manufacturer by combining organic innovation with strategic acquisitions. In 1999, Perrigo re-domiciled to Ireland, establishing a presence in Europe and positioning itself to expand into new markets. Over the decades, Perrigo has integrated manufacturing facilities, R&D centers and distribution networks in the United States, Europe, the Middle East and Africa, allowing the company to serve more than 100 countries worldwide.
The company operates four key business segments: Consumer Self Care–North America, Consumer Self Care–International, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients (APIs). Its North America arm focuses on store-brand OTC and nutritional products, while the international segment supplies branded and private-label products across Europe, the Middle East and emerging markets. Perrigo’s prescription division concentrates on generic pharmaceuticals, delivering cost-effective alternatives to branded drugs, and its API unit manufactures key chemical components for both internal use and external customers.
Perrigo is led by President and Chief Executive Officer Eyal Desheh and supported by a seasoned executive team with experience in pharmaceuticals, consumer goods and global supply chain management. The board emphasizes quality, regulatory compliance and innovation, investing in new product development and digital capabilities to enhance customer engagement. With a commitment to affordability, accessibility and consumer well-being, Perrigo continues to expand its footprint in core markets while pursuing strategic growth opportunities across the healthcare landscape.
